Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.39
+0.81 (14.52%)
May 5, 2026, 11:56 AM EDT - Market open
Evolus Market Cap
Evolus has a market cap or net worth of $420.81 million as of May 5, 2026. Its market cap has decreased by -34.54% in one year.
Market Cap
420.81M
Enterprise Value
482.58M
1-Year Change
-34.54%
Ranking
Category
Stock Price
$6.39
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $420.81M, an increase of 55.11%. That is a compound annual growth rate of 5.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 346.80M | -19.55% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 524.48M |
| Kamada | 475.82M |
| Emergent BioSolutions | 440.63M |
| Canopy Growth | 426.50M |
| Akebia Therapeutics | 400.51M |
| SIGA Technologies | 331.00M |
| Organogenesis Holdings | 328.68M |
| Aurora Cannabis | 205.63M |